CN Patent

CN116284240B — 一种仿生类肽防冰抗冻剂及其制备方法和应用

Assigned to Jiangsu University · Expires 2026-04-14 · 0y expired

What this patent protects

本发明提供了一种仿生类肽防冰抗冻剂及其制备方法和应用，属于生物高分子合成领域；本发明所述仿生类肽防冰抗冻剂以含羟基侧链作为亲水侧链、烷基链作为疏水侧链，通过固相亚单体合成法按照设计的结构合成得到含有不同亲疏水序列的仿生类肽防冰抗冻剂；所述仿生类肽防冰抗冻剂能够与冰晶表面形成氢键相互作用抑制水分子运动、疏水烷基通过疏水作用来影响及阻止水分子聚集，进而能有效调控冰晶生长。

USPTO Abstract

本发明提供了一种仿生类肽防冰抗冻剂及其制备方法和应用，属于生物高分子合成领域；本发明所述仿生类肽防冰抗冻剂以含羟基侧链作为亲水侧链、烷基链作为疏水侧链，通过固相亚单体合成法按照设计的结构合成得到含有不同亲疏水序列的仿生类肽防冰抗冻剂；所述仿生类肽防冰抗冻剂能够与冰晶表面形成氢键相互作用抑制水分子运动、疏水烷基通过疏水作用来影响及阻止水分子聚集，进而能有效调控冰晶生长。

Drugs covered by this patent

Patent Metadata

Patent number
CN116284240B
Jurisdiction
CN
Classification
—
Expires
2026-04-14
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.